Matches in Wikidata for { <http://www.wikidata.org/entity/Q102331190> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q102331190 description "2020 ވަނަ އަހަރުގެ ނޮވެމްބަރުމަހުގެ 23ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q102331190 description "article scientifique publié en 2020" @default.
- Q102331190 description "artículu científicu espublizáu en payares de 2020" @default.
- Q102331190 description "scientific article published on 23 November 2020" @default.
- Q102331190 description "wetenschappelijk artikel" @default.
- Q102331190 description "наукова стаття, опублікована 23 листопада 2020" @default.
- Q102331190 name "Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long-term Results of Two Phase III Randomized Controlled Trials" @default.
- Q102331190 name "Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long-term Results of Two Phase III Randomized Controlled Trials" @default.
- Q102331190 name "Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long-term Results of Two Phase III Randomized Controlled Trials" @default.
- Q102331190 type Item @default.
- Q102331190 label "Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long-term Results of Two Phase III Randomized Controlled Trials" @default.
- Q102331190 label "Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long-term Results of Two Phase III Randomized Controlled Trials" @default.
- Q102331190 label "Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long-term Results of Two Phase III Randomized Controlled Trials" @default.
- Q102331190 prefLabel "Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long-term Results of Two Phase III Randomized Controlled Trials" @default.
- Q102331190 prefLabel "Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long-term Results of Two Phase III Randomized Controlled Trials" @default.
- Q102331190 prefLabel "Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long-term Results of Two Phase III Randomized Controlled Trials" @default.
- Q102331190 P1433 Q102331190-57693966-725C-4B75-9929-BC024127C6F4 @default.
- Q102331190 P1476 Q102331190-C4B18387-E8F8-4A11-A003-D7FEFBAB4257 @default.
- Q102331190 P2093 Q102331190-4FE3F908-01A1-49A2-AAB0-1A18D60FC357 @default.
- Q102331190 P2093 Q102331190-84A3169C-6CF3-4AB0-85F0-1EC74B0C08B4 @default.
- Q102331190 P2093 Q102331190-95BCAA94-4396-478E-B6CD-5C8C14207604 @default.
- Q102331190 P2093 Q102331190-D76B130A-14D2-4A10-AB2F-33B9E5AE277D @default.
- Q102331190 P2093 Q102331190-DEE5E019-5E20-4AF3-AA97-B85CD6481D31 @default.
- Q102331190 P31 Q102331190-E8648763-02F0-4ECB-964A-E503B91FC746 @default.
- Q102331190 P356 Q102331190-8C44F1F9-9295-40D0-9EA5-23791D2001C9 @default.
- Q102331190 P50 Q102331190-88051614-E9B1-4E48-9377-A70A4DC1A884 @default.
- Q102331190 P50 Q102331190-BAA472C6-0A4F-41F9-BB30-3FA7419C3484 @default.
- Q102331190 P50 Q102331190-CD61C813-1767-4099-A9DE-73D1C53420AB @default.
- Q102331190 P50 Q102331190-D474375A-FD36-48EC-ABFD-EB77312376BE @default.
- Q102331190 P50 Q102331190-E4B5832D-92B2-43D9-98C4-3E1A050BACAC @default.
- Q102331190 P50 Q102331190-F4B2360A-74F6-4D6C-BC68-619ECAF7DBC1 @default.
- Q102331190 P577 Q102331190-376A8E31-ADC6-4FB7-8CBC-5EFFDF4EFB96 @default.
- Q102331190 P698 Q102331190-13E6C4EE-7CC7-4817-8BAE-0AB6ACD9B279 @default.
- Q102331190 P921 Q102331190-F69B80C6-E452-4875-B645-E235D83A1ABE @default.
- Q102331190 P356 ACR.24517 @default.
- Q102331190 P698 33227175 @default.
- Q102331190 P1433 Q15754720 @default.
- Q102331190 P1476 "Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long-term Results of Two Phase III Randomized Controlled Trials" @default.
- Q102331190 P2093 "Abhijit Shete" @default.
- Q102331190 P2093 "Isabelle Gilloteau" @default.
- Q102331190 P2093 "Laure Gossec" @default.
- Q102331190 P2093 "Mikkel Østergaard" @default.
- Q102331190 P2093 "Nicole Williams" @default.
- Q102331190 P31 Q13442814 @default.
- Q102331190 P356 "10.1002/ACR.24517" @default.
- Q102331190 P50 Q37829390 @default.
- Q102331190 P50 Q52876893 @default.
- Q102331190 P50 Q56418325 @default.
- Q102331190 P50 Q65660760 @default.
- Q102331190 P50 Q88283567 @default.
- Q102331190 P50 Q92751391 @default.
- Q102331190 P577 "2020-11-23T00:00:00Z" @default.
- Q102331190 P698 "33227175" @default.
- Q102331190 P921 Q52849 @default.